AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11099808
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with the same paired‐unpaired sequence but with a compound containing two different letters from the reinforced ones.
Trial: 9750603
Drug: Emla cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Emla cream + 50 vol% nitrous oxide in oxygen
Trial: 16469323
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol therapy
Trial: 3524093
Drug: Occlusal adjustment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal adjustment (with 19 patients also receiving splint therapy)
Trial: 19745641
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg single dose of triazolam
Trial: 19745641
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg divided between 2 equal doses for 60 minutes
Trial: 19745641
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg divided among 3 doses for 90 minutes
Trial: 15269853
Drug: Coronal preflaring
RxNorm normalized name: Corona Udder Butter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronal preflaring using size 25# and 20# ProFile.06 taper NiTi rotary instrument
Trial: 16390757
Drug: Risedronate 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 2.5 mg
Trial: 9150326
Drug: L-ASA (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-ASA (90 mg x mL(‐1))
Trial: 9150326
Drug: Placebo (glycine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (glycine, 30 mg x mL(‐1))
Trial: 30048027
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (64 mmol daily)
Trial: 19031076
Drug: Chloroquine treatment
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine treatment (25 mg/kg body weight, orally on three consecutive days)
Trial: 11194533
Drug: 44 g-DG
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 44 g-DG emulsion
Trial: 9258482
Drug: Heparin 50
RxNorm normalized name: HEPARIN 5000 UNT/ML SYRINGE 1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 50 IU/kg
Trial: 9258482
Drug: Heparin 100
RxNorm normalized name: heparin 100 units/mL injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 100 IU/kg
Trial: 24617349
Drug: Isoflavone-rich soy
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone-rich soy protein (25 grams daily, 91 mg of aglycone weight isoflavones: 52 mg genistein, 36 mg daidzein, 3 mg glycitein)
Trial: 18549459
Drug: Ibuprofen-Phosphatidylcholine (PC)
RxNorm normalized name: phosphatidylcholine, soybean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen-Phosphatidylcholine (PC)
Trial: 21146375
Drug: Early improvement
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early improvement in positive affect during the first week of treatment
Trial: 16195989
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin iontophoresis (0.1 ml Humulin R 100 IU/ml diluted 1/10 with 0.9 % saline)
Trial: 11805506
Drug: Topical netilmicin
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical netilmicin
Trial: 11805506
Drug: Topical netilmicin
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical netilmicin and Gentamicin
Trial: 7673657
Drug: Sertraline 100
RxNorm normalized name: sertraline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 100 mg
Trial: 7673657
Drug: Sertraline 200
RxNorm normalized name: sertraline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 200 mg
Trial: 2667209
Drug: Campath-1M (10-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Campath-1M (10-day course postoperatively) + high-dose cyclosporine (17 mg/kg)
Trial: 2667209
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (high-dose cyclosporine alone)
Trial: 11445789
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (DEX) 0.6 mg/kg, maximum 16 mg for 2 days
Trial: 11445789
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (PRED) 2 mg/kg, maximum 60 mg for 5 days
Trial: 28945675
Drug: Taurine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (40 mg·kg body mass) in noncaffeine consumers
Trial: 28945675
Drug: Taurine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (40 mg·kg body mass) in caffeine consumers deprived of caffeine
Trial: 28945675
Drug: Taurine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (40 mg·kg body mass) in noncaffeine consumers (isometric)
Trial: 28945675
Drug: Taurine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taurine (40 mg·kg body mass) in caffeine consumers deprived of caffeine (isometric)
Trial: 21355378
Drug: Temsirolimus (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (175 mg per week for 3 weeks, followed by 75 mg or 25 mg per week)
Trial: 21355378
Drug: Temsirolimus (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (higher dose)
Trial: 21355378
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (various other treatments)
Trial: 21355378
Drug: Temsirolimus (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (both dose regimens)
Trial: 10463902
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments (specific details not provided)
Trial: 1607498
Drug: Plasma exchange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma exchange therapy (PE)
Trial: 20153888
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg orally twice daily
Trial: 28600758
Drug: Pessary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pessary treatment
Trial: 22453323
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy (pelvic floor muscle training and continence strategies)
Trial: 15659145
Drug: Everolimus 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 1.5 mg/d
Trial: 15866684
Drug: Everolimus 3
RxNorm normalized name: everolimus 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3 mg/d
Trial: 10221663
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg daily for 8 weeks
Trial: 10221663
Drug: Probucol 500
RxNorm normalized name: probucol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol 500 mg daily for 8 weeks
Trial: 2142866
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of epidural sufentanil (5 micrograms/h)
Trial: 2142866
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of lumbar epidural morphine (0.5 mg/h)
Trial: 673790
Drug: VM 26
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VM 26 (60 mg/m2), methyl‐C.C.N.U. (120 mg/m2) and 5 fluoro‐uracile
Trial: 673790
Drug: B.C.G. (simultaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B.C.G. (simultaneous application)
Trial: 31516010
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg per day for six weeks
Trial: 25218708
Drug: Ixabepilone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixabepilone (40 mg/m(2) every 21 days)
Trial: 25218708
Drug: Ixabepilone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixabepilone (40 mg/m(2) every 21 days) with cetuximab (400 mg/m(2) loading dose, followed by 250 mg/m(2) once weekly)
Trial: 17288854
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy and pre-medication (group B)
Trial: 11136647
Drug: Olanzapine plus
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine plus fluoxetine
Trial: 10440302
Drug: Intravenous mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous mitomycin (1.4 mg/m2) and fluorouracil (166.7 mg/m2) twice weekly for 3 weeks after surgery, and oral UFT (uracil plus tegafur, 300 mg daily) for 18 months
Trial: 6108445
Drug: Combined vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vaccine and immunoglobulin
Trial: 28575646
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol (UP) active-treatment group
Trial: 28575646
Drug: Medication-only control
RxNorm normalized name: CALCIUM 0.8 ORAL TABLET [OnlyCal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-only control group
Trial: 24450301
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg/day for 12 weeks
Trial: 23903032
Drug: Zembrin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zembrin (25 mg)
Trial: 17702958
Drug: Intraarterial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarterial infusion of urokinase (UK)
Trial: 14671730
Drug: Hypothetical drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical drug trial consent process
Trial: 11090788
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/benazepril 10 mg
Trial: 1799889
Drug: Benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril 10 mg
Trial: 9234577
Drug: VICOP-B (idarubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VICOP-B (idarubicin 8 mg/sqm)
Trial: 9234577
Drug: VICOP-B (idarubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VICOP-B (idarubicin 10 mg/sqm)
Trial: 9234577
Drug: VACOP-B (doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VACOP-B (doxorubicin 50 mg/sqm)
Trial: 2125869
Drug: Combined acupuncture
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined acupuncture and medication (ear needling and body needling with half-dosage Innovar and 0.1% lidocaine for scalp infiltration)
Trial: 31090748
Drug: Internal hexagon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal hexagon implants (IHC)
Trial: 31090748
Drug: External hexagon
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External hexagon implants (EHC)
Trial: 27464593
Drug: Terlipressin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (1 mg every 6 hours)
Trial: 26693035
Drug: EECP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EECP therapy
Trial: 26932695
Drug: Sham EECP
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham EECP therapy
Trial: 22463698
Drug: Triplet antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triplet antiplatelet therapy (TAT)
Trial: 22463698
Drug: Double-dose antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose antiplatelet therapy (DDAT)
Trial: 21415052
Drug: sequential monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sequential monotherapy
Trial: 19116965
Drug: step-up combination
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: step-up combination therapy starting with methotrexate
Trial: 19116965
Drug: initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: initial combination therapy including tapered high-dose prednisone
Trial: 19116965
Drug: initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: initial combination therapy with methotrexate and infliximab
Trial: 18158044
Drug: High-pressure spray
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-pressure spray of 0.3 mL 2% lidocaine using the MadaJet Medical Injector
Trial: 18158044
Drug: Traditional vasal
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional vasal block with three 1.7-mL ampules of mepivacaine using a 27-gauge needle
Trial: 15193965
Drug: Psychotherapy group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy group (short-term psychodynamic therapy)
Trial: 15193965
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standardized glucocorticoid therapy)
Trial: 11779284
Drug: Olanzapine cotherapy
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine cotherapy (5-20 mg/d)
Trial: 6097137
Drug: Suxamethonium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 1.0 mg/kg
Trial: 2869713
Drug: Suxamethonium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 0.5 mg/kg
Trial: 9807607
Drug: Suxamethonium 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 0.25 mg/kg
Trial: 9807607
Drug: Suxamethonium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 0.5 mg/kg or more
Trial: 7621645
Drug: Dexamethasone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (2 mg daily for 2 days)
Trial: 7621645
Drug: Ephedrine sulphate
RxNorm normalized name: Ephedrine sulphate
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ephedrine sulphate (40 mg daily for 2 days)
Trial: 2488093
Drug: Amiodarone infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone infusion (10-20 mg/kg in saline infusion within 4 to 10 hours through a central vein)
Trial: 2488093
Drug: Glucose-insulin-potassium (GIK)
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-insulin-potassium (GIK) infusion (150-300 g of glucose, 25-50 IU of insulin, and 80-120 mEq of KCl in 1000 cc of water at a rate of 1.5-2.0 ml/g/hour)
Trial: 320630
Drug: Naproxen-Sodium (NS)
RxNorm normalized name: Naproxen Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen-Sodium (NS) 1100 mg
Trial: 21829566
Drug: B subunit‐killed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B subunit‐killed whole‐cell and killed whole‐cell‐only oral cholera vaccines
Trial: 19588485
Drug: Baseline insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baseline insulin levels (highest tertile)
Trial: 19588485
Drug: Repeated measurements
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated measurements of serum insulin
Trial: 17349075
Drug: Blood orange
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL SPRAY [All Clean Premium Hand Sanitizer Blood Orange]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood orange juice (BOJ, 300 ml providing 150 mg vitamin C)
Trial: 11587503
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release (SR) paracetamol (Panadol Extend)
Trial: 11587503
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release (IR) paracetamol (Panadol)
Trial: 17083392
Drug: Doxazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (2 mg)
Trial: 24465671
Drug: Daily repetitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily repetitive training using the rubber hand illusion paradigm
Trial: 22179931
Drug: DepoFoam bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DepoFoam bupivacaine 600 mg
Trial: 22179931
Drug: bupivacaine HCl
RxNorm normalized name: bupivacaine HCl
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupivacaine HCl 200 mg
Trial: 19334061
Drug: MRI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI treatment effects
Trial: 17229229
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg (group K)
Trial: 17229229
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg (group G)
Trial: 17229229
Drug: Ketamine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.25 mg + Granisetron 1.5 mg (group KG)
Trial: 11665964
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (prednisolone, methotrexate, and sulfasalazine)
Trial: 30657406
Drug: Cocaine/Other Stimulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine/Other Stimulant group
Trial: 30657406
Drug: Other Stimulant
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other Stimulant group (primarily methamphetamine)
Trial: 25638351
Drug: Telehealth PTSD
RxNorm normalized name: Guaifenesin 100 mg in 5 mL ORAL LIQUID [SelectHealth Tussin DM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealth PTSD program, motivational interviewing-based smoking cessation curricula via telehealth device, weekly motivational interviewing counseling phone calls
Trial: 22981045
Drug: Plasma Exchange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma Exchange (PE) plus conventional sepsis treatment
Trial: 22981045
Drug: Control (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Conventional sepsis treatment only)
Trial: 21306237
Drug: Sunitinib at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib at a dose of 37.5 mg per day
Trial: 16881243
Drug: Observation tool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation tool for evaluating parent-child interaction; details on dosage and duration not applicable.
Trial: 11202321
Drug: Open treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open treatment
Trial: 8517512
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 25 ml
Trial: 8517512
Drug: Morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 5 mg in normal saline 25 ml
Trial: 8517512
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bupivacaine 0.5% 12.5 ml and 5 mg of morphine in normal saline 25 ml
Trial: 8517512
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 25 ml
Trial: 3031840
Drug: Misonidazole 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole 1.2 g/m2 orally on treatment day
Trial: 29151116
Drug: No alpha-1
RxNorm normalized name: alpha 1-antitrypsin
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No alpha-1 blocker (Group 1)
Trial: 24886179
Drug: Internet-delivered Cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered Cognitive Behavior Therapy (iCBT) program consisting of 8 weekly modules with post-session feedback support.
Trial: 24886179
Drug: Waiting-list control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting-list control group receiving access to the treatment at week 8.
Trial: 18602724
Drug: 11-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-valent pneumococcal protein D (PD)-conjugate study vaccine
Trial: 18602724
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (HAV) (control)